News
MedPage Today on MSN2d
Novel Antihypertensive Reduced Blood Pressure in Primary AldosteronismA phase III trial of baxdrostat for primary aldosteronism is now underway. Developer AstraZeneca is also testing it as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback